Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome
Clinical trial NCT02738450 · COMPLETED
Trial details
- NCT number
- NCT02738450
- Sponsor
- AC Immune SA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.